A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic Encephalopathy

NCT05737784 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

SCN2A-DEE
Epilepsy

Interventions

DRUG: PRAX-222 - Initial Dose
DRUG: PRAX-222 - Initial Ascending Doses
DRUG: PRAX-222 - Optional Ascending Doses
DRUG: PRAX-222 - Fixed Doses
PROCEDURE: Placebo

Sponsor

Praxis Precision Medicines